United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 29, 2026 · Filed Apr 30, 2026

On Apr 29, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$571.22 for US$5.43M under a trading plan, leaving 40,513 shares. Filed Apr 30, 2026 (Form 4).

Sold
9,500 shares
Price
US$571.22 average (US$565.27 to US$573.89)
Value
US$5.43M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 29, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 29, 2026Common StockSale8US$565.2750,005Direct
Apr 29, 2026Common StockSale32US$566.3449,973Direct
Apr 29, 2026Common StockSale135US$567.7249,838Direct
Apr 29, 2026Common StockSale322US$568.9849,516Direct
Apr 29, 2026Common StockSale2,674US$570.0246,842Direct
Apr 29, 2026Common StockSale2,432US$570.8744,410Direct
Apr 29, 2026Common StockSale1,786US$572.0642,624Direct
Apr 29, 2026Common StockSale1,654US$572.8940,970Direct
Apr 29, 2026Common StockSale457US$573.8940,513Direct

Source

View original at SEC

Related